STOCK TITAN

EDAP TMS SA to Announce Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP) will release its financial results for the fourth quarter and year ended December 31, 2020 on March 30, 2021, after market close. A conference call led by CEO Marc Oczachowski and CFO François Dietsch is scheduled for March 31, 2021, at 8:30 AM EDT. The call will discuss key financial metrics and developments related to the company’s innovative medical devices, enhancing its position in therapeutic ultrasound.

Positive
  • Conference call scheduled to discuss quarterly results could provide insights into company performance.
  • EDAP TMS holds a strong position in the global therapeutic ultrasound market.
Negative
  • None.

Company to host conference call and webcast on Wednesday, March 31 at 8:30 am EDT

LYON, France, March 23, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2020 after the markets close on Tuesday, March 30, 2021.

An accompanying conference call and webcast will be conducted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, and François Dietsch, Chief Financial Officer. The call will be held at 8:30am EDT on Wednesday, March 31, 2021. Please refer to the information below for conference call dial-in information and webcast registration.

Conference Call & Webcast
Wednesday, March 31st @ 8:30am Eastern Time
Domestic:                    877-451-6152
International:              201-389-0879
Passcode:                    13717550
Webcast:                     http://public.viavid.com/index.php?id=143913

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer.  EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
Jeremy Feffer
LifeSci Advisors, LLC
212-915-2568
jeremy@lifesciadvisors.com

 


FAQ

When will EDAP TMS announce its fourth-quarter financial results?

EDAP TMS will announce its fourth-quarter financial results on March 30, 2021, after the market closes.

What time is the EDAP TMS conference call?

The EDAP TMS conference call is scheduled for March 31, 2021, at 8:30 AM EDT.

Who will lead the EDAP TMS conference call?

The conference call will be conducted by CEO Marc Oczachowski and CFO François Dietsch.

Where can I find the webcast for EDAP TMS's conference call?

The webcast for the EDAP TMS conference call can be accessed via the company's official website.

EDAP TMS SA

NASDAQ:EDAP

EDAP Rankings

EDAP Latest News

EDAP Stock Data

82.77M
37.10M
42.37%
0.12%
Medical Distribution
Healthcare
Link
United States of America
Lyon